Anti-Mouse CD5 (Lyt-1) - FITC - 500 µg

All|Primary Monoclonal Antibodies

2 - 8°C Wet Ice

CD5 (Lyt-1) is fundamental to immune homeostasis and immune tolerance, with many functions in T and B cells1. CD5 acts as a modulator of T and B cell receptor signaling as well as a cell survival receptor in T and B cells. CD5 is also involved in thymocyte selection, T cell effector differentiation, induces regulatory T cells in the periphery, and modulates Th17 and Th2 differentiation as well as dendritic cell function. Because of its role as an immune checkpoint modulator, CD5 is a target of immunotherapy in the treatment of cancer, autoimmune disease, and infection.53-7.3 was generated by immunizing LOU/Ws1/M rats with mouse (SJL/J or C3H/HeJ) spleencells or thymocyte membranes2. Spleen cells were subsequently fused with mouse myeloma NS-1 to produce a hybridoma. The antigen target CD5 (Lyt-1) was confirmed by comparative immunoprecipitation as well as blocking experiments using conventional alloantisera.

0.2 mg/ml

CD5 (Lyt-1) is a marker used to identify T cells, B1-a cells, B cell chronic lymphocytic leukemia cells, regulatory T cell (Tregs), regulatory B cells (IL-10 producing Bregs), and the earliest thymic progenitors. CD5 is also expressed on all lymphocytes except natural killer cells.